Webinar on CRISPR/Cas9 on May 11

The American Association for the Advancement of Science and the journal Science will present a free, one-hour webinar about CRISPR/Cas9 in drug discovery at noon Eastern on May 11.

Here’s an excerpt from the registration page:

During this webinar, our expert panel will address:

• Areas of the drug discovery process where gene editing will have the most immediate and long term impact
• The current and future role of CRISPR/Cas9 in target discovery, hit identification, and lead optimization (compared with siRNA screening)
• The challenges that CRISPR/Cas9 brings to screening and assay development, particularly with respect to cell analysis
• The importance of carrying out binding studies following gene editing.

The speakers will be Lorenz Mayr of AstraZeneca and Ralph Garippa of Memorial Sloan Kettering Cancer Center.

Register here.

Categories: Uncategorized